AptarGroup, Inc. with ticker code (ATR) have now 6 confirmed analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 152 and 110 calculating the mean target price we have $125.67. Given that the stocks previous close was at $119.03 this now indicates there is a potential upside of 5.6%. Also worth taking note is the 50 day moving average now sits at $115.42 while the 200 day moving average is $107.68. The total market capitalization for the company now stands at $7,885m. Visit the company website at: https://www.aptar.com
The potential market cap would be $8,325m based on the market consensus.
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through three segments: Aptar Pharma, Aptar Beauty, and Aptar Closures. The company provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. It also sells pumps, closures, aerosol valves, accessories, and sealing solutions to the personal care and home care markets; and pumps and decorative components to the beauty market. In addition, the company offers dispensing and non-dispensing closures, elastomeric flow control components, spray pumps, and aerosol valves to the food and beverage markets. The company primarily sells its products and services through its own sales force, as well as independent representatives and distributors in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
The company has a dividend yield of 1.28% with the ex dividend date set at 1-2-2023 (DMY).
Other points of data to note are a P/E ratio of 33.59, revenue per share of 50.8 and a 5.64% return on assets.
